692 results on '"Saelens, Xavier"'
Search Results
2. Proteomic data and structure analysis combined reveal interplay of structural rigidity and flexibility on selectivity of cysteine cathepsins
3. A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses
4. Promises and challenges of single-domain antibodies to control influenza
5. Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted
6. Need for standardization of Influenza A virus-induced cell death in vivo to improve consistency of inter-laboratory research findings
7. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017
8. Author response: The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017
9. Mosaic display of stable hemagglutinin monomers induces broad immune responses
10. Yeast-based production platform for potent and stable heavy chain-only antibodies
11. Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase
12. ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection
13. Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity
14. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
15. Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
16. The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration
17. Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity
18. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza
19. Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity
20. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017
21. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017
22. A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults : A First-in-Humans Study
23. Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL
24. Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
25. GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
26. Clinical Potential of Prefusion RSV F-specific Antibodies
27. Reverse engineering synthetic antiviral amyloids
28. Intracellular Delivery of mRNA in Adherent and Suspension Cells by Vapor Nanobubble Photoporation
29. Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant
30. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
31. Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus
32. Protein Synthesis Persists during Necrotic Cell Death
33. Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants
34. Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
35. Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B
36. Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair
37. Cov2MS: An Automated and Quantitative Matrix-Independent Assay for Mass Spectrometric Measurement of SARS-CoV-2 Nucleocapsid Protein
38. GM-CSF treatment prevents respiratory syncytial virus–induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation
39. Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
40. Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
41. Author Correction: A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine
42. Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
43. An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25
44. A general approach to identify low-frequency variants within influenza samples collected during routine surveillance
45. CD8+ T cell immunity against human respiratory syncytial virus
46. Cutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines
47. Soluble Recombinant Influenza Vaccines
48. Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein
49. Fas-Induced Necrosis
50. Challenges and advances towards the rational design of mRNA vaccines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.